Fatigue in Ehlers-Danlos Syndrome (EDS)

Intro to Fatigue in EDS

Fatigue is a common yet often misunderstood symptom in individuals with hypermobile Ehlers-Danlos Syndrome (hEDS). Unlike typical tiredness, which resolves with rest, fatigue in hEDS is persistent and often resistant to conventional remedies. This chronic exhaustion is sometimes misdiagnosed as Chronic Fatigue Syndrome (CFS), a vague label that can hinder further investigation into the root causes of fatigue in hypermobility disorders.

Understanding the underlying factors contributing to fatigue in EDS can help patients and healthcare providers develop targeted management strategies.

Key contributors to fatigue in individuals with hEDS include:

1. Orthostatic Intolerance and Poor Blood Flow

Postural Orthostatic Tachycardia Syndrome (POTS) and other forms of dysautonomia are common in EDS. These conditions impair blood flow regulation, leading to insufficient oxygen delivery to tissues. Poor oxygenation can cause both muscular fatigue and cognitive impairment, often described as "brain fog."

2. Medication-Induced Fatigue

Many EDS patients take multiple medications to manage pain, dysautonomia, and MCAS. Some of these medications, such as antihistamines (e.g., Benadryl), sedatives, and beta-blockers, contribute to lethargy. While each medication alone may have a mild effect, the combination can significantly increase fatigue.

3. Ligament Laxity and Muscle Overuse

People with EDS experience ligament laxity, meaning their ligaments are too loose to provide adequate joint stability. This forces their muscles to work harder to maintain posture and movement, leading to muscle fatigue. Unlike individuals with normal ligament support, EDS patients constantly engage their muscles, even while at rest, resulting in chronic fatigue.

4. Mast Cell Activation Syndrome (MCAS)

MCAS is frequently seen in individuals with EDS and results in widespread inflammation. Patients often describe a constant flu-like feeling, which contributes to overall fatigue. Chronic inflammation from MCAS can exacerbate exhaustion and reduce daily functionality.

5. Sleep Disorders: Sleep Apnea and Non-Restorative Sleep

EDS is associated with obstructive and central sleep apnea due to laxity in airway tissues. Tracheomalacia, or softening of the trachea, can further contribute to breathing difficulties during sleep. Additionally, high sympathetic nervous system activity in EDS prevents restful sleep, leaving individuals exhausted despite sleeping for a full night.

6. Mitochondrial Dysfunction

In EDS, mitochondrial dysfunction impairs oxygen utilization, leading to exercise intolerance and muscle weakness. This dysfunction may stem from genetic factors, autoimmune issues, or chronic infections.

Mitochondrial Function and ATP Production

Mitochondria, often referred to as the "powerhouses of the cell," play a crucial role in energy production by generating adenosine triphosphate (ATP) through oxidative phosphorylation. ATP serves as the primary energy currency for nearly all cellular processes, including muscle contraction, neurotransmission, and metabolic homeostasis.

Mitochondrial Dysfunction and Fatigue

Several mechanisms link mitochondrial dysfunction to fatigue:

• Reduced ATP Availability – Insufficient ATP production directly affects cellular energy demands, leading to muscle weakness, cognitive fatigue, and exercise intolerance.
• Oxidative Stress – An imbalance between reactive oxygen species (ROS) production and antioxidant defenses damages mitochondrial DNA (mtDNA), proteins, and lipids, further impairing energy production.
• Inflammatory Response – Chronic inflammation, commonly observed in conditions associated with fatigue, can lead to mitochondrial damage through cytokine-mediated effects on electron transport chain function.
• Dysregulated Mitochondrial Biogenesis – Impaired signaling pathways (e.g., PGC-1α, a key regulator of mitochondrial replication) may reduce the number of functional mitochondria, exacerbating energy deficits.

Clinical Implications and Potential Interventions

Addressing mitochondrial dysfunction may provide therapeutic avenues for fatigue management. Strategies include:

• Nutritional Support – Coenzyme Q10, L-carnitine, riboflavin, and magnesium support mitochondrial energy metabolism.
• Exercise Therapy – Moderate aerobic and resistance training can enhance mitochondrial efficiency and biogenesis, improving fatigue symptoms over time.
• Antioxidant Therapy – N-acetylcysteine (NAC) and alpha-lipoic acid (ALA) help reduce oxidative stress, supporting mitochondrial integrity.
• Metabolic Modulation – Interventions like intermittent fasting or ketogenic diets may enhance mitochondrial resilience by optimizing fatty acid oxidation.

Mitochondrial function is integral to cellular energy balance, and its impairment is a recognized contributor to fatigue. Understanding the interplay between mitochondrial bioenergetics, oxidative stress, and inflammation provides insights into fatigue-related disorders and potential therapeutic strategies.

7. Hormonal Dysregulation

People with EDS often experience hormonal imbalances, such as symptoms of hypothyroidism despite normal lab results. Pituitary and adrenal insufficiency may also develop due to cerebral hypoperfusion, leading to chronic fatigue and poor stress tolerance.

8. Intracranial Pressure Abnormalities

EDS patients frequently experience abnormal intracranial pressure:

• High Intracranial Pressure (ICP) – Restriction of venous blood flow can elevate pressure inside the skull, affecting pituitary function and hormone regulation. This condition, known as Empty Sella Syndrome, can contribute to fatigue.
• Low Intracranial Pressure (ICP) – Cerebrospinal fluid (CSF) leaks, common in EDS, can lead to low ICP, causing severe headaches that worsen when upright and improve when lying down. This condition is also linked to profound fatigue.

9. Autoimmune Dysfunction

A subset of EDS patients exhibit autoimmune-like symptoms, where their immune system mistakenly attacks their own tissues. Chronic pain and fatigue are hallmark symptoms of autoimmune involvement in EDS.

10. Nutritional Deficiencies

Gastrointestinal dysmotility is prevalent in EDS, causing chronic nausea, constipation, diarrhea, and malabsorption. Patients often develop food intolerances and deficiencies in essential nutrients, including fat-soluble vitamins. Small Intestinal Bacterial Overgrowth (SIBO) is also common, further exacerbating fatigue.

11. Anemia and Low Ferritin Levels

Iron is crucial for oxygen transport in the blood. Many EDS patients have low ferritin levels, indicating poor iron storage. Even when traditional anemia is not diagnosed, suboptimal ferritin levels can contribute to persistent fatigue.

By recognizing the multifaceted nature of fatigue in EDS, healthcare professionals can move beyond generic diagnoses like Chronic Fatigue Syndrome (CFS) and provide more precise, effective interventions.

For EDS patients, understanding the reasons behind their fatigue can be empowering, offering hope for targeted management strategies that improve quality of life.

‍